AFP and hepatocellular carcinoma: This could be explained by the larger tumor burdens seen already at the time of diagnosis in patients with infiltrative type HCC as represented by a higher incidence of larger, multifocal, vessel-invading tumors and a higher serum level of AFP and PIVKA-II compared to those with the nodular type HCC.